Xeomin
XEOMIN®
ASK YOUR HEALTH CARE PROFESSIONAL IF XEOMIN®
IS RIGHT FOR YOU.
XEOMIN®
is an unfunded medicine for aesthetic procedures so you will need to pay for the medicine and any other
charges. XEOMIN®
(Incobotulinumtoxin A) 50, 100 Units is a Prescription Medicine. Indications: In adults, for the
treatment of cervical dystonia; blepharospasm; spasticity of the upper limb; upper facial lines: glabellar frown lines,
lateral periorbital lines (crow’s feet), horizontal forehead lines. XEOMIN® has both risks and benefits, consult your
doctor if XEOMIN®
is right for you. Further information on the risks and benefits of XEOMIN® can be found in the
Consumer Medicine Information (CMI) available from www.medsafe.govt.nz or by calling 0800 822 310. Use strictly as
directed. If symptoms continue or you have side effects, see your doctor, pharmacist or health care professional.
Common side effects include: Headaches; nausea; tenderness, swelling, redness, numbness or bruising of the skin;
dry eye; heavy feeling of eyelid/ eyebrow/forehead; face/brow not symmetrical, dropping eyelids/eyebrows. Serious
side effects are rare and include allergic reactions. XEOMIN® and Merz Aesthetics are registered trademarks of Merz
Pharma GMbH & Co. KGaA.
Dysport
DYSPORT®
ASK YOUR HEALTH CARE PROFESSIONAL IF DYSPORT®
IS RIGHT FOR YOU.
Dysport® is an unfunded medicine for aesthetic indications. Product and treatment costs apply.
Dysport® is a prescription medicine contains 300 or 500 U of botulinum toxin, distributed in NZ by Galderma Australia
Pty Ltd, North Sydney, NSW, for the treatment of frown lines and crow’s feet around the eyes. Dysport® has risks and
benefits. Ask your healthcare professional if Dysport® is right for you and to explain the possible side effects. Tell them
if any side effects concern you. ALWAYS FOLLOW THE INSTRUCTIONS YOU ARE GIVEN. For details on precautions and
side effects, see the Consumer Medicines Information at www.medsafe.govt.nz. Dysport® is a registered trademark of
Ipsen Pty Ltd. Galderma is a registered trademark of Galderma Holding S.A
Profhilo
PROFHILO®
ASK YOUR HEALTH CARE PROFESSIONAL IF PROFHILO®
IS RIGHT FOR YOU.
PROFHILO® and PROFHILO® Body is an unfunded medicine so you will need to pay for the medicine and any other
charges. PROFHILO® and PROFHILO® Body are Class III medical devices containing 16mg high molecular weight (MW)
hyaluronic acid (HA) + 16mg low MW HA/1mL syringe that is obtained through a patented treatment (NAHYCO®
Hybrid Technology) which provides it with unique characteristics for its use in the face and body, where it is
injected with an ultrafine needle to plump the skin to smooth away wrinkles and improve texture and skin quality.
PROFHILO® must only be administered by a medical practitioner or a qualified nurse injector (who operates under the
supervision of a medical practitioner). Treatment costs and normal practitioner’s fees will apply. PROFHILO® has risks
and benefits. Do not use with treatments such a laser resurfacing or medium deep skin-peeling. Do not inject into
inflamed areas or intravenously or intramuscularly. Please consult your medical practitioner regarding its suitability for
you, or if there are any questions regarding precautions and side effects. For further product information, please refer
to your medical practitioner or the Instructions for Use leaflet at Dermocosmètica PTY LTD, Australia. PROFHILO® is a
registered trademark of IBSA.
Sunekos
Coming soon.